Vigmed Holding AB (publ) reschedules interim report

The Board of Directors of Vigmed Holding AB (publ) has decided to reschedule the publication of the interim report for January - September 2016. The company will publish the report on November 15, 2016.

The Board of Directors of Vigmed Holding AB (publ) has decided to reschedule the publication of the interim report for January - September 2016. The company will publish the report on November 15, 2016.

For further information contact:

Chairman of the board, Sten Dahlborg + 70 836 9419 or CEO, Henrik Olsen +46  76 349 7364

Vigmed is a Swedish medical technology company whose mission is to eliminate needlestick injuries and the associated risk of cross infections with blood-borne infectious diseases by offering the market unique needle-protected products. Vigmed is headquartered in Helsingborg, Sweden. Vigmed’s share is traded on NASDAQ OMX First North in Stockholm (ticker VIG) and has approximately  5 600 shareholders. Remium Nordic AB is the Company’s Certified Advisor.  Additional information about the company can be found on Vigmed’s website: www.vigmed.com/investor

Tags:

About Us

Vigmed is a Swedish medical technology company whose mission is to eliminate needlestick injuries by offering the market unique needle-protected products. Vigmed is headquartered in Helsingborg, Sweden. Vigmed’s share is traded on NASDAQ OMX First North in Stockholm (ticker VIG) and the company has approximately 5 600 shareholders. Remium Nordic AB is the Company’s Certified Advisor. Additional information can be found on Vigmed’s home page: www.vigmed.com

Subscribe

Documents & Links